ABOUT US

Our Mission

Our mission is to develop curative therapies for chronic wound, cancer, and inflammatory disease patients with our multi-target cell and gene therapy platform.

Our Vision

Our goal is to create solid clinical safety and efficacy data in Diabetic Foot Ulcer, other chronic wounds and deadly cancers, and to engage with strategic partners to enable market entry to ensure that this game-changing technology platform benefits millions of patients throughout the world.

SCIENTIFIC ADVISORY BOARDS

DIABETIC FOOT ULCER

VENOUS LEG ULCER

Picture of Kirsi Isoherranen

KIRSI ISOHERRANEN

Logo of Helsinki University Hospital
Picture of Joachim Dissemond

JOACHIM DISSEMOND

Logo of University Medicine Essen
Picture of Arkadiusz Jawień

ARKADIUSZ JAWIEŃ

Logo of Nicolaus Copernicus University
Picture of Valentina Dini

VALENTINA DINI

Logo of University of Pisa

BOARD OF DIRECTORS

Serial Entrepreneur, Board Professional and Biotech Business Advisor

Biotech Investor, Senior Executive and Board Professional

Scientist, Biotech Investor and Board Professional

TEAM MEMBERS

Director of Genetic Engineering & Manufacturing

Head of Quality & Regulatory Affairs

Head of Pre-Clinical & Pharmacology

Senior Clinical Project Manager

Picture of Matleena Piiroinen

MATLEENA PIIROINEN

Drug Safety Officer

Marketing & Communications Manager